Aktuelle Berichte
News Funktionen
Weitere Funktionen
11 März 2024
Qiagen N.V.
Annual financial report 2023
1 November 2023
Qiagen N.V.
Q3 statement / Q3 financial report 2023
Qiagen N.V.
Q3 statement / Q3 financial report 2023
10 August 2023
Qiagen N.V.
Half-yearly financial report 2023
5 Mai 2023
Qiagen N.V.
Q1 statement / Q1 financial report 2023
13 März 2023
Qiagen N.V.
Annual financial report 2022
9 November 2022
Qiagen N.V.
Q3 statement / Q3 financial report 2022
29 Juli 2022
Qiagen N.V.
Half-yearly financial report 2022
29 April 2022
Qiagen N.V.
Annual financial report 2021
Qiagen N.V.
Q1 statement / Q1 financial report 2022
8 November 2021
Qiagen N.V.
Q3 statement / Q3 financial report 2021
2 August 2021
Qiagen N.V.
Half-yearly financial report 2021
5 Mai 2021
Qiagen N.V.
Q1 statement / Q1 financial report 2021
5 März 2021
Qiagen N.V.
Annual financial report 2020
2 November 2020
Qiagen N.V.
Q3 statement / Q3 financial report 2020
5 August 2020
Qiagen N.V.
Half-yearly financial report 2020
8 Mai 2020
Qiagen N.V.
Q1 statement / Q1 financial report 2020
2 März 2020
Qiagen N.V.
Annual financial report 2019
31 Oktober 2019
Qiagen N.V.
Q3 statement / Q3 financial report 2019
1 August 2019
Qiagen N.V.
Half-yearly financial report 2019
8 Mai 2019
Qiagen N.V.
Q1 statement / Q1 financial report 2019
6 März 2019
Qiagen N.V.
Annual financial report 2018
31 Oktober 2018
Qiagen N.V.
Q3 statement / Q3 financial report 2018
1 August 2018
Qiagen N.V.
Half-yearly financial report 2018
7 Mai 2018
Qiagen N.V.
Q1 statement / Q1 financial report 2018
6 März 2018
Qiagen N.V.
Annual financial report 2017
8 November 2017
Qiagen N.V.
Q3 statement / Q3 financial report 2017
31 Juli 2017
Qiagen N.V.
Half-yearly financial report 2017
4 Mai 2017
Qiagen N.V.
Q1 Mitteilung / Q1 Finanzbericht 2017
Aktuelle News
News Funktionen
Weitere Funktionen
7 Januar 2024
Qiagen N.V.
QIAGEN N.V.: QIAGEN zahlt rund 300 Millionen Dollar durch einen synthetischen Aktienrückkauf an seine Aktionärinnen und Aktionäre zurück
9 November 2022
Qiagen N.V.
Release of a capital market information
3 November 2022
Qiagen N.V.
Qiagen N.V.: Elizabeth E. Tallett, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to …
Qiagen N.V.
Qiagen N.V.: Dr. Metin Colpan, Release of 457 Restricted Stock Units based on grant made on October 31, 2012. Exercise Price: $0.00. Closing price on October 31, 2022: $43.56. Subsequent to the …
2 November 2022
Qiagen N.V.
Qiagen N.V.